Erkek Osteoporozu

Burcu Önder

Research Article

Erkek Osteoporozu

Year 2019, Volume: 11 Issue: 3, 96 - 98, 03.05.2019

Burcu Önder

Abstract

Osteoporoz kemik mineral yoğunluğunda azalma ve kemik kırılganlığında artış ile
seyreden metabolik bir kemik hastalığıdır. Beklenen yaşam süresinin uzaması osteoporozu
ciddi bir morbidite ve mortalite nedeni haline getirmektedir.

Keywords

osteoporoz, erkekosteoporoz, erkek

References

1. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical epidemiyology of male osteoporosis: a review of the recent literature. Clinical Epidemiyology 2015:7 65-76.
2. Sutton R AL, Dian L, Guy P. Osteoporosis in men: an underrecognized and undertreated problem. BC Medical Journal. 2011: 53 no: 10
3. Rosen CJ, Kurland ES, Vereault D et al. Association between serum insülin growth factor-1 (IGF-1) and a simple sequence repeat in IGF-1 gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998; 83: 2286- 2290
4. Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM, Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 2004; 89: 2286- 2290
5. Adler AA. Osteoporosis in men: a review. Bone research 2014:2 14001
6. Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporosis Int 2011;22:1845-1853
7. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2012;77: 453-468
8. Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009;94:1214- 22.
9. Papaioannou A,Morin S, Cheung AM et al. 2010 clinical practice guidelines fort he diagnosis and management of osteoporosis in Canada: Summary CMAJ 2010;182:1864-73
10. Orwoll E, Ettinger M,Weiss S et al. Alendronate for the treatment of osteoporosis in men. N Eng J Med 2000;343:604-10
11. Nayak S, Greesspan S. Osteoporosis treatment efficacy for men: a systematic review and meta-analysis. Journal of American Geriatrics Society 2016
12. Schoofs MW, van der Klift M, Hofman A et al. Thiazide diüretics and the risk for hip fracture. Ann Intern Med 2003;139:476-82.
13. Kaufman JM, Audran G, Bianchi G, Braga M et al.Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clini Endoc Metab 2013 Vol 98.
14. Smith MR, Egerdie B, Hernandez TN, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Eng J Med 2009;361:745-755

Year 2019, Volume: 11 Issue: 3, 96 - 98, 03.05.2019

Burcu Önder

Abstract

References

1. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical epidemiyology of male osteoporosis: a review of the recent literature. Clinical Epidemiyology 2015:7 65-76.
2. Sutton R AL, Dian L, Guy P. Osteoporosis in men: an underrecognized and undertreated problem. BC Medical Journal. 2011: 53 no: 10
3. Rosen CJ, Kurland ES, Vereault D et al. Association between serum insülin growth factor-1 (IGF-1) and a simple sequence repeat in IGF-1 gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998; 83: 2286- 2290
4. Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM, Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 2004; 89: 2286- 2290
5. Adler AA. Osteoporosis in men: a review. Bone research 2014:2 14001
6. Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporosis Int 2011;22:1845-1853
7. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2012;77: 453-468
8. Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009;94:1214- 22.
9. Papaioannou A,Morin S, Cheung AM et al. 2010 clinical practice guidelines fort he diagnosis and management of osteoporosis in Canada: Summary CMAJ 2010;182:1864-73
10. Orwoll E, Ettinger M,Weiss S et al. Alendronate for the treatment of osteoporosis in men. N Eng J Med 2000;343:604-10
11. Nayak S, Greesspan S. Osteoporosis treatment efficacy for men: a systematic review and meta-analysis. Journal of American Geriatrics Society 2016
12. Schoofs MW, van der Klift M, Hofman A et al. Thiazide diüretics and the risk for hip fracture. Ann Intern Med 2003;139:476-82.
13. Kaufman JM, Audran G, Bianchi G, Braga M et al.Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clini Endoc Metab 2013 Vol 98.
14. Smith MR, Egerdie B, Hernandez TN, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Eng J Med 2009;361:745-755

There are 14 citations in total.

Details

Primary Language	Turkish
Subjects	Internal Diseases
Journal Section	makaleler
Authors	Burcu Önder This is me
Publication Date	May 3, 2019
Published in Issue	Year 2019 Volume: 11 Issue: 3

Cite

APA	Önder, B. (2019). Erkek Osteoporozu. Klinik Tıp Aile Hekimliği, 11(3), 96-98.
AMA	Önder B. Erkek Osteoporozu. Aile Hekimliği. May 2019;11(3):96-98.
Chicago	Önder, Burcu. “Erkek Osteoporozu”. Klinik Tıp Aile Hekimliği 11, no. 3 (May 2019): 96-98.
EndNote	Önder B (May 1, 2019) Erkek Osteoporozu. Klinik Tıp Aile Hekimliği 11 3 96–98.
IEEE	B. Önder, “Erkek Osteoporozu”, Aile Hekimliği, vol. 11, no. 3, pp. 96–98, 2019.
ISNAD	Önder, Burcu. “Erkek Osteoporozu”. Klinik Tıp Aile Hekimliği 11/3 (May 2019), 96-98.
JAMA	Önder B. Erkek Osteoporozu. Aile Hekimliği. 2019;11:96–98.
MLA	Önder, Burcu. “Erkek Osteoporozu”. Klinik Tıp Aile Hekimliği, vol. 11, no. 3, 2019, pp. 96-98.
Vancouver	Önder B. Erkek Osteoporozu. Aile Hekimliği. 2019;11(3):96-8.

Download Cover Image

Article Files

Full Text